Journal Mobile Options
Table of Contents
Vol. 18, No. 4, 2005
Issue release date: July–August 2005
Skin Pharmacol Appl Skin Physiol 2005;18:195–200

Protective Effects of Different Marigold (Calendula officinalis L.) and Rosemary Cream Preparations against Sodium-Lauryl-Sulfate-Induced Irritant Contact Dermatitis

Fuchs S.M. · Schliemann-Willers S. · Fischer T.W. · Elsner P.
Department of Dermatology and Allergology, Friedrich-Schiller University Jena, Jena, Germany

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


In the present study, we evaluated the protective action of cream preparations containing seven different types of marigold and rosemary extracts in vivo in healthy volunteers with experimentally induced irritant contact dermatitis (ICD). Marigold and rosemary extracts in base cream DAC (Deutscher Arzneimittel-Codex = German Pharmaceutical Codex) were tested in a 4-day repetitive irritation test using sodium lauryl sulfate. The effect was evaluated visually and quantified by noninvasive bioengineering methods, namely chromametry and tewametry. When the test products were applied parallel to the induction period of ICD, a statistically significant protective effect of all cream preparations was observed by all methods. This effect, although not statistically significant, was superior to control by undyed marigold und faradiol ester-enriched extracts in chromametry and by dyed and undyed rosemary extracts in tewametry. The sequential treatment (postirritation) once a day for 5 days was without any effect. Thus, a protective effect of some marigold and rosemary extracts against ICD could be shown in the elicitation phase.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Wollenberg A, Sharma S, von Bubnoff D, Geiger E, Haberstok J, Bieber T: Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol 2001;107:519–525.
  2. Zonneveld IM, Rubins A, Jablonska S, et al: Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. Arch Dermatol 1998;134:1101–1102.
  3. Thiers BH: Topical steroid therapy of atopic skin diseases. Allergy Proc 1989;10:413–416.
  4. Aruoma OI, Halliwell B, Aeschbach R, Loligers J: Antioxidant and pro-oxidant properties of active rosemary constituents: Carnosol and carnosic acid. Xenobiotica 1992;22:257–268.
  5. Kim SJ, Han D, Moon KD, Rhee JS: Measurement of superoxide dismutase-like activity of natural antioxidants. Biosci Biotechnol Biochem 1995;59:822–826.
  6. Singletary KW: Rosemary extract and carnosol stimulate rat liver glutathione-S-transferase and quinone reductase activities. Cancer Lett 1996;100:139–144.
  7. Chan MM, Ho CT, Huang HI: Effects of three dietary phytochemicals from tea, rosemary and turmeric on inflammation-induced nitrite production. Cancer Lett 1995;96:23–29.
  8. Schulz V, Hansel R, Tyler VE: Rational Phytotherapy. New York, Springer, 1998.
  9. Zitterl-Eglseer K, Sosa S, Jurenitsch J, et al: Anti-oedematous activities of the main triterpendiol esters of marigold (Calendula officinalis L). J Ethnopharmacol 1997;57:139–144.
  10. Della Loggia R, Tubaro A, Sosa S, Becker H, Saar S, Isaac O: The role of triterpenoids in the topical anti-inflammatory activity of Calendula officinalis flowers. Planta Med 1994;60:516–520.
  11. Fischer TW, Greif C, Wigger-Alberti W, Elsner P: Instrumentelle Methoden zur Bewertung der Sicherheit und Wirksamkeit von Kosmetika. Akt Dermatol 1998;24:243–250.
  12. Frosch PJ, Kligman AM: The soap chamber test. A new method for assessing the irritancy of soaps. J Am Acad Dermatol 1979;1:35–41.
  13. Pinnagoda J, Tupker RA, Agner T, Serup J: Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1990;22:164–178.
  14. Elsner P: Chromametry. Hardware Measuring Principles and Standardization Measurements. Boca Raton, CRC Press, 1994.
  15. Bikowski J: The use of therapeutic moisturizers in various dermatologic disorders. Cutis 2001;68:3–11.
  16. Held E, Lund H, Agner T: Effect of different moisturizers on SLS-irritated human skin. Contact Dermatitis 2001;44:229–234.
  17. De Paepe K, Hachem JP, Vanpee E, Goossens A, Germaux MA, Lachapelle JM, Lambert J, Matthieu L, Roseeuw D, Suys E, Van Hecke E, Rogiers V: Beneficial effects of a skin tolerance-tested moisturizing cream on the barrier function in experimentally-elicited irritant and allergic contact dermatitis. Contact Dermatitis 2001;44:337–343.
  18. Reider N, Komericki P, Hausen BM, Fritsch P, Aberer W: The seamy side of natural medicine: Contact sensitization to arnica (Arnica montana L) and marigold (Calendula officinalis L). Contact Dermatitis 2001;45:269–272.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50